Back
Terns Pharmaceuticals 10K Form
Sell
42
TERN
Terns Pharmaceuticals
Last Price:
5.79
Seasonality Move:
55.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TERN News And Ratings
See the #1 stock for the next 7 days that we like better than TERN
TERN Financial Statistics
Sales & Book Value
Annual Sales: | $1M |
---|---|
Cash Flow: | $-16.46M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.29 |
Price / Book: | 1.35 |
Profitability
EPS (TTM): | -1.18000 |
---|---|
Net Income (TTM): | $-88.07M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Terns Pharmaceuticals Earnings Forecast
Key Terns Pharmaceuticals Financial Ratios
- Per Share Earnings over the last 6 years have been positive in 3 years.
Terns Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | TERN |
Website: | ternspharma.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
TERN Technical Analysis vs Fundamental Analysis
Sell
42
Terns Pharmaceuticals (TERN)
is a Sell
Is Terns Pharmaceuticals a Buy or a Sell?
-
Terns Pharmaceuticals stock is rated a Sell
The current Terns Pharmaceuticals [TERN] share price is $5.79. The Score for TERN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.